1
|
Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Khalil A, von Dadelszen P, Papageorghiou AT, Alfirevic Z, Vollmer B. Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial. BJOG 2024. [PMID: 38923115 DOI: 10.1111/1471-0528.17888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2024] [Revised: 05/28/2024] [Accepted: 05/31/2024] [Indexed: 06/28/2024]
Abstract
OBJECTIVE Severe early-onset fetal growth restriction (FGR) causes stillbirth, neonatal death and neurodevelopmental impairment. Poor maternal spiral artery remodelling maintains vasoactive responsiveness but is susceptible to treatment with sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, which may improve perinatal outcomes. DESIGN Superiority, double-blind randomised controlled trial. SETTING A total of 20 UK fetal medicine units. POPULATION Pregnancies affected by FGR, defined as an abdominal circumference below the tenth centile with absent end-diastolic flow in the umbilical artery between 22+0 and 29+6 weeks of gestation. METHODS Treatment with sildenafil (25 mg three times/day) or placebo until delivery or 32 weeks of gestation. MAIN OUTCOME MEASURES All infants alive at hospital discharge were assessed for cardiovascular function and cognitive, speech/language and neuromotor impairment at 2 years of age. The primary outcome was survival without cerebral palsy or neurosensory impairment, or a Bayley-III composite score of >85. RESULTS In total, 135 women were randomised between November 2014 and July 2016 (70 to sildenafil and 65 to placebo). We previously published that there was no improvement in time to delivery or perinatal outcomes with sildenafil. In all, 75 babies (55.5%) were discharged alive, with 61 infants eligible for follow-up (32 sildenafil and 29 placebo). One infant died (placebo), three mothers declined and ten mothers were uncontactable. There was no difference in neurodevelopment or blood pressure following treatment with sildenafil. Infants who received sildenafil had a larger head circumference at 2 years of age (median difference 49.2 cm, IQR 46.4-50.3, vs 47.2 cm, 95% CI 44.7-48.9 cm). CONCLUSIONS Sildenafil therapy did not prolong pregnancy or improve perinatal outcomes and did not improve infant neurodevelopment in FGR survivors. Therefore, sildenafil should not be prescribed for this condition.
Collapse
Affiliation(s)
- Andrew Sharp
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
- Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK
| | - Christine Cornforth
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
- Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK
| | - Richard Jackson
- Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK
| | - Jane Harrold
- Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK
| | - Mark A Turner
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
- Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK
| | - Louise C Kenny
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
| | - Philip N Baker
- College of Life Sciences, University of Leicester, Leicester, UK
| | - Edward D Johnstone
- Faculty of Medicine Biology and Health, Maternal and Fetal Health Research Centre, School of Medical Sciences, University of Manchester, Manchester, UK
| | - Asma Khalil
- Fetal Medicine Unit, St George's Hospital, University of London, London, UK
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK
| | - Peter von Dadelszen
- Department of Women's and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK
| | - Aris T Papageorghiou
- Fetal Medicine Unit, St George's Hospital, University of London, London, UK
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK
| | - Zarko Alfirevic
- Department of Women's and Children's Health, University of Liverpool, Liverpool, UK
- Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK
| | - Brigitte Vollmer
- Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
- Paediatric Neurology, Southampton Children's Hospital, University Hospitals Southampton NHS Foundation Trust, Southampton, UK
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
2
|
Xiong X, Carvalho N, Huang L, Chen G, Jones R, Devlin N, Mulhern B, Dalziel K. Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2-4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL). PHARMACOECONOMICS 2024; 42:147-161. [PMID: 38280126 PMCID: PMC11169045 DOI: 10.1007/s40273-024-01355-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/25/2023] [Indexed: 01/29/2024]
Abstract
OBJECTIVE This study examines the psychometric properties of the Child Health Utility 9D (CHU9D) proxy version administered to parents/caregivers of 2-4-year-old Australian children compared with Pediatric Quality of Life Inventory™ version 4.0 (PedsQL). METHODS Data collected in 2021/2022 from parents/caregivers of 2-4-year-olds from the Australian pediatric multi-instrument comparison study were used. Feasibility, ceiling/floor effects, test-retest reliability, convergent validity, known-group validity, and responsiveness were assessed. RESULTS A total of 842 caregivers completed the survey at baseline, with 513 completing the follow-up survey. The CHU9D did not demonstrate ceiling effects in the sample with special health care needs, with only 6% of respondents reporting best levels for all nine dimensions. CHU9D correlated with PedsQL moderately-to-strongly between comparable items (correlation coefficients 0.34-0.70). CHU9D was able to differentiate between groups with known health differences with moderate-to-large effect sizes (Cohen's d 0.58-2.03). Moderate test-retest reliability was found for CHU9D in those reporting no health change at a 2-day follow-up (ICC 0.52). A standard response mean (SRM) of 0.25-0.44 was found for children with changes in general health and a SRM of 0.72-0.82 for children who reported worsened health when developing new illnesses, indicating small-to-large responsiveness according to different definitions of health changes. Compared with PedsQL, CHU9D had similar known-group validity and responsiveness and slightly poorer test-retest reliability. CONCLUSION The CHU9D was found to be valid and reliable to measure health-related quality-of-life in children aged 2-4 years, although with relatively low test-retest reliability in some dimensions. Further development and validation work is warranted.
Collapse
Affiliation(s)
- Xiuqin Xiong
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia
| | - Natalie Carvalho
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia
| | - Li Huang
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia
| | - Gang Chen
- Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia
| | - Renee Jones
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia
| | - Nancy Devlin
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia
| | - Brendan Mulhern
- Centre for Health Economics Research and Evaluation, University of Technology Sydney, Ultimo, Australia
| | - Kim Dalziel
- Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia.
| |
Collapse
|
3
|
Viani K, Bernardes BF, Veiga MN, Viani RC, Barbuto TM, Barr RD. Translation and cultural adaptation of the Health Utilities Preschool to Brazilian Portuguese. Hematol Transfus Cell Ther 2024; 46:131-136. [PMID: 36868939 DOI: 10.1016/j.htct.2023.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2022] [Accepted: 01/20/2023] [Indexed: 02/25/2023] Open
Abstract
INTRODUCTION Health research is particularly important in low- and middle-income countries (LMICs), where improvements must be achieved with limited resources, and where the great majority of the world's population, especially children, live. Improvements in public health detection in Brazil have resulted in cancer becoming the most prevalent cause of death by disease in the group aged 1 to 19 years, hence, delivering cost-effective care to the group is a priority. Preference-based measures of health status and health-related quality of life (HRQL) integrate morbidity and mortality and provide utility scores for the estimation of quality-adjusted life years to be used in cost-effectiveness analyses and economic evaluation. The generic preference-based instrument Health Utilities - Preschool (HuPS) measures the health status of young children and is applicable to the age group 2 to 5 years, who carry the highest incidence of cancer in childhood. METHODS The translation of the HuPS classification system followed recommended protocols from published guidelines. Forward and backward translations were performed by a team of six qualified professionals and linguistic validation was undertaken with a sample of parents of preschool children. MAIN RESULTS Initial disagreements on individual words occurring in 0.5-1.5% were resolved by consensus. A final version of the instrument was validated by the sample of parents. CONCLUSIONS The translation and cultural adaptation of the HuPS into Brazilian Portuguese were accomplished as the first step in the validation of the HuPS instrument in Brazil.
Collapse
Affiliation(s)
- Karina Viani
- Instituto de Tratamento do Câncer Infantil (ITACI), Instituto da Criança e do Adolescente, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brazil.
| | | | | | | | - Tomas Marzagão Barbuto
- Instituto de Tratamento do Câncer Infantil (ITACI), Instituto da Criança e do Adolescente, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brazil
| | | |
Collapse
|
4
|
Hsing JC, Lin BJ, Pulendran U, Jani SG, Chiang WL, Chiang TL, Wang CJ. Development and Validation of Age-Specific Resilience Instruments for Early Childhood Assessment: A Taiwan Birth Cohort Study. Acad Pediatr 2022; 22:1142-1152. [PMID: 35691535 DOI: 10.1016/j.acap.2022.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 05/26/2022] [Accepted: 06/05/2022] [Indexed: 01/19/2023]
Abstract
BACKGROUND We sought to develop and validate age-specific instruments for measuring early childhood resilience at ages 3, 5 and 8 in the Taiwan Birth Cohort Study, a national longitudinal study. METHODS Using data from 18,553 mother-infant pairs, we conducted exploratory factor analysis (EFA) on a simple random half of our sample. We then used the remaining half of these data for confirmatory factor analysis (CFA) to further assess the fit of 3 CFA models (ie, first-order, second-order, and bifactor). Psychometric properties, distributions, and inter-item and inter-factor correlations of each instrument were also evaluated. RESULTS EFA and CFA showed that the bifactor model of resilience (which included a general resilience factor and 5 specific factors) had the best fit for all 3 resilience scales, with 19 items at year 3, 18 items at year 5, and 19 items at year 8. All 3 resilience scales showed good psychometric properties, including construct validity, internal consistency, and normal distributions. For predictive validity, we found that in the face of adversity (measured by the High Risk Family Score), individuals with high resilience scores at age 3 had better general health scores at ages 3, 5, and 8 compared to those with low resilience scores. CONCLUSIONS We describe the development and validation of age-appropriate survey instruments to assess resilience in young children at the population level. These instruments can be used to better understand how resilience can impact child health over time, and to identify key factors that can foster resilience.
Collapse
Affiliation(s)
- Julianna C Hsing
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Epidemiology and Population Health, Stanford University School of Medicine (JC Hsing), Stanford, Calif
| | - Bea-Jane Lin
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif
| | - Uma Pulendran
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif
| | - Shilpa G Jani
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif
| | - Wan-Lin Chiang
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; College of Public Health, National Taiwan University (W-L Chiang and T-L Chiang), Taipei, Taiwan
| | - Tung-Liang Chiang
- College of Public Health, National Taiwan University (W-L Chiang and T-L Chiang), Taipei, Taiwan.
| | - C Jason Wang
- Center for Policy, Outcomes, and Prevention, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif; Department of Pediatrics, Stanford University School of Medicine (JC Hsing, B-J Lin, U Pulendran, SG Jani, W-L Chiang, and CJ Wang), Stanford, Calif.
| |
Collapse
|
5
|
You Y, van Grieken A, Estévez-López F, Yang-Huang J, Raat H. Factors Associated With Early Elementary Child Health-Related Quality of Life: The Generation R Study. Front Public Health 2022; 9:785054. [PMID: 35155347 PMCID: PMC8829330 DOI: 10.3389/fpubh.2021.785054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Accepted: 12/22/2021] [Indexed: 11/30/2022] Open
Abstract
Aim To identify the factors associated with health-related quality of life (HRQOL) among early elementary age children (5–6 years) from a general population sample. Methods We analyzed data of 4,202 children from the Generation R Study, a population-based cohort study in the Netherlands. Children's physical and psychosocial HRQOL were measured using the Child Health Questionnaire Parent Form 28 (CHQ-PF28). Associations between socio-demographic characteristics (child age, sex, ethnic background, family situation, parental educational level, parental employment status, and net household income), health-related lifestyle behaviors (physical activity and screen time), health conditions (number of chronic conditions, emotional and behavioral problems, and family functioning) and children's physical and psychosocial HRQOL were assessed using multivariate regression analyses. Results Mean child age was 6.0 years (SD: 0.43); 63.6% had a majority (Dutch) ethnic background. Children with a non-western ethnic background, and children of unemployed mothers had a lower physical HRQOL (all p < 0.05). Older children, boys, and children from single-parent or low educated families had a lower psychosocial HRQOL (all p < 0.05). Children from a low income household family, children having chronic conditions or emotional and behavioral problems, or from families with relatively high “pathological family functioning” reported both lower physical and psychosocial HRQOL (all p < 0.05). Conclusion Indicators of adverse socioeconomic and family circumstances and indicators of child health problems were associated with lower HRQOL. Public health initiatives to improve HRQOL of children should prioritize children from a low socioeconomic status or with less favorable health conditions from early age onwards.
Collapse
Affiliation(s)
- Yueyue You
- The Generation R Study Group, Erasmus Medical Center, Rotterdam, Netherlands
- Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands
| | - Amy van Grieken
- Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands
| | - Fernando Estévez-López
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Center, Rotterdam, Netherlands
| | - Junwen Yang-Huang
- The Generation R Study Group, Erasmus Medical Center, Rotterdam, Netherlands
- Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands
| | - Hein Raat
- Department of Public Health, Erasmus Medical Center, Rotterdam, Netherlands
- *Correspondence: Hein Raat
| |
Collapse
|
6
|
Verstraete J, Lloyd AJ, Jelsma J. Performance of the Toddler and Infant (TANDI) Health-Related Quality of Life Instrument in 3-4-Year-Old Children. CHILDREN-BASEL 2021; 8:children8100920. [PMID: 34682184 PMCID: PMC8534352 DOI: 10.3390/children8100920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/07/2021] [Revised: 10/12/2021] [Accepted: 10/13/2021] [Indexed: 11/16/2022]
Abstract
The Toddler and Infant (TANDI) dimensions of Health-Related Quality of Life assess 'age appropriate' behaviour and measurement could be extended to older children. A sample of 203 children 3-4 years of age was recruited, and their caregivers completed the TANDI, Pediatric Quality of Life Inventory (PedsQL) and EQ-5D-Y Proxy. Spearman and Pearson's correlation coefficients, and Kruskal-Wallis H-test were used to explore the feasibility, known-group validity, discriminate validity and concurrent validity of the TANDI. Children with a health condition (n = 142) had a lower ceiling effect (p = 0.010) and more unique health profiles (p < 0.001) than the healthy group (n = 61). The TANDI discriminated between those with and without a health condition. In children with a health condition, the TANDI discriminated between clinician rated severity of the health condition. The TANDI had moderate to strong correlations with similar PedsQL and EQ-5D-Y items and scores. The TANDI is valid for children aged 3-4 years and is recommended for children with a health condition, whereas the PedsQL may be better for healthy children. The TANDI is recommended for studies with young children whereas the EQ-5D-Y Proxy is recommended for a sample including older children or for longitudinal studies with preschoolers. Further work on the TANDI is recommended to establish test-retest reliability and responsiveness.
Collapse
Affiliation(s)
- Janine Verstraete
- Department of Paediatrics and Child Health, Division of Pulmonology, University of Cape Town, Klipfontein Road, Rondebosch, Cape Town 7700, South Africa
- Correspondence:
| | | | - Jennifer Jelsma
- Deparment of Health and Rehabilitation Sciences, Division of Physiotherapy, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa;
| |
Collapse
|
7
|
LoRe D, Mattson C, Feltman DM, Fry JT, Brennan KG, Arnolds M. Physician Perceptions on Quality of Life and Resuscitation Preferences for Extremely Early Newborns. Am J Perinatol 2021. [PMID: 34352923 DOI: 10.1055/s-0041-1733782] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
OBJECTIVE The study aimed to explore physician views on whether extremely early newborns will have an acceptable quality of life (QOL), and if these views are associated with physician resuscitation preferences. STUDY DESIGN We performed a cross-sectional survey of neonatologists and maternal fetal medicine (MFM) attendings, fellows, and residents at four U.S. medical centers exploring physician views on future QOL of extremely early newborns and physician resuscitation preferences. Mixed-effects logistic regression models examined association of perceived QOL and resuscitation preferences when adjusting for specialty, level of training, gender, and experience with ex-premature infants. RESULTS A total of 254 of 544 (47%) physicians were responded. A minority of physicians had interacted with surviving extremely early newborns when they were ≥3 years old (23% of physicians in pediatrics/neonatology and 6% in obstetrics/MFM). The majority of physicians did not believe an extremely early newborn would have an acceptable QOL at the earliest gestational ages (11% at 22 and 23% at 23 weeks). The majority of physicians (73%) believed that having an extremely preterm infant would have negative effects on the family's QOL. Mixed-effects logistic regression models (odds ratio [OR], 95% confidence interval [CI]) revealed that physicians who believed infants would have an acceptable QOL were less likely to offer comfort care only at 22 (OR: 0.19, 95% CI: 0.05-0.65, p < 0.01) and 23 weeks (OR: 0.24, 95% CI: 0.07-0.78, p < 0.02). They were also more likely to offer active treatment only at 24 weeks (OR: 9.66, 95% CI: 2.56-38.87, p < 0.01) and 25 weeks (OR: 19.51, 95% CI: 3.33-126.72, p < 0.01). CONCLUSION Physician views of extremely early newborns' future QOL correlated with self-reported resuscitation preferences. Residents and obstetric physicians reported more pessimistic views on QOL. KEY POINTS · Views of QOL varied by specialty and level of training.. · Contact with former extremely early newborns was limited.. · QOL views were associated with preferred resuscitation practices..
Collapse
Affiliation(s)
- Danielle LoRe
- Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, New York
| | | | - Dalia M Feltman
- Department of Pediatrics, Northshore University HealthSystem, Evanston, Illinois and Pritzker School of Medicine, University of Chicago, Chicago, Illinois
| | - Jessica T Fry
- Department of Pediatrics and Division of Neonatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois and Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| | - Kathleen G Brennan
- Department of Pediatrics, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, New York
| | - Marin Arnolds
- Department of Pediatrics, Northshore University HealthSystem, Evanston, Illinois and Pritzker School of Medicine, University of Chicago, Chicago, Illinois
| |
Collapse
|
8
|
Alessi J, de Oliveira GB, Franco DW, Becker AS, Knijnik CP, Kobe GL, Amaral BB, de Brito A, Schaan BD, Telo GH. Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial. Acta Diabetol 2021; 58:899-909. [PMID: 33723649 PMCID: PMC7959296 DOI: 10.1007/s00592-021-01690-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2020] [Accepted: 02/22/2021] [Indexed: 01/22/2023]
Abstract
AIMS To assess the impact of teleintervention on mental health parameters in type 2 diabetes patients during the coronavirus disease 2019 (COVID-19) pandemic. METHODS This is a controlled randomized trial for a multidisciplinary telehealth intervention in Southern Brazil, with social distancing measures. Adults aged 18 years or older with previous diagnosis of type 2 diabetes were included in the study. The intervention performed was a set of strategies to help patients stay healthy during the COVID-19 pandemic and included the maintaining of telephone contacts and providing educational materials on issues related to mental health, healthy habits, and diabetes care. The primary outcome was a positive screening for mental health disorders (Self-Reporting Questionnaire) after 16 weeks of intervention. A positive screening for mental health disorders was considered when the survey scored greater than or equal to 7. Secondary outcomes included a positive screening for diabetes-related emotional distress (Problem Areas in Diabetes), eating (Eating Attitudes Test), and sleep disorders (Mini Sleep Questionnaire). Comparisons with χ2 tests for dichotomous outcomes, along with the Mann-Whitney U test, was used for between group analyses. RESULTS A total of 91 individuals agreed to participate (46 intervention group and 45 control group). There were no differences in demographic and clinical data at baseline. After 16 weeks of follow-up, a positive screening for mental health disorders was found in 37.0% of participants in the intervention group vs. 57.8% in the control group (P = 0.04). Diabetes-related emotional distress was found in 21.7% of participants in the intervention group vs. 42.2% in the control group (P = 0.03). No differences were found between groups with regard to eating and sleep disorders. CONCLUSION This study demonstrated that maintaining remote connections with health professionals during social distancing and quarantine have the potential to reduce the prevalence of positive screening for mental health disorders and diabetes-related emotional distress in adults with type 2 diabetes.
Collapse
Affiliation(s)
- Janine Alessi
- Postgraduate Program in Endocrinology, Universidade Federal Do Rio Grande Do Sul, Rua Ramiro Barcelos, nº 2400, 2° andar, Porto Alegre, RS, 90035-003, Brazil.
- Division of Internal Medicine, Hospital São Lucas da Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6690, 6º andar, Porto Alegre, RS, 90160-092, Brazil.
| | - Giovana Berger de Oliveira
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Debora Wilke Franco
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Alice Scalzilli Becker
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Carolina Padilla Knijnik
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Gabriel Luiz Kobe
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Bibiana Brino Amaral
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| | - Ariane de Brito
- Postgraduate Program in Endocrinology, Universidade Federal Do Rio Grande Do Sul, Rua Ramiro Barcelos, nº 2400, 2° andar, Porto Alegre, RS, 90035-003, Brazil
| | - Beatriz D Schaan
- Postgraduate Program in Endocrinology, Universidade Federal Do Rio Grande Do Sul, Rua Ramiro Barcelos, nº 2400, 2° andar, Porto Alegre, RS, 90035-003, Brazil
- School of Medicine, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, nº 2400, 3° andar, Porto Alegre, RS, 90035-003, Brazil
- Endocrinology Division, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, prédio 12, 4° andar, Porto Alegre, RS, 90035-003, Brazil
| | - Gabriela Heiden Telo
- Division of Internal Medicine, Hospital São Lucas da Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6690, 6º andar, Porto Alegre, RS, 90160-092, Brazil
- School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
- Medicine and Health Sciences Program, Pontifícia Universidade Católica da PUCRS, Av. Ipiranga, nº 6681, prédio 12A, Porto Alegre, RS, 90160-092, Brazil
| |
Collapse
|